AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Nano-based water filtration market seen reaching $910.4 billion by 2035
AGP
The global nano-based water filtration market is projected to grow from $237.454 billion in 2025 to $910.404 billion by 2035, driven by water scarcity, stricter contaminant rules and rising infrastructure spending.
ABL Diagnostics rolls out UltraGene Viral Meningitis after CE-IVD registration
AGP
ABL Diagnostics has made UltraGene Viral Meningitis commercially available after CE-IVD registration through ABL SA Luxembourg.
ABL Diagnostics launches UltraGene Respiratory Pathogens 21 after CE-IVD registration
AGP
ABL Diagnostics said UltraGene Respiratory Pathogens 21 is now commercially available after CE-IVD registration through ABL SA Luxembourg, giving laboratories a new automated respiratory PCR assay for 21 pathogens.
DSV opens direct Luxembourg-Indianapolis pharma air route
AGP
DSV launched a new Air ThermoDirect connection through Indianapolis International Airport to strengthen temperature-controlled pharmaceutical shipping between Luxembourg and the U.S. hub. The route is designed to improve cold-chain reliability,…
ABL Diagnostics secures BSI for IVDR transition
AGP
ABL Diagnostics said it has secured a partnership with BSI to move its CE-IVD portfolio through Europe’s IVDR transition, keeping products available through the regulatory deadline windows.
ÉireComposites builds satellite hardware for ESA’s Altius mission
AGP
ÉireComposites has manufactured three carbon fibre components for ESA’s Altius ozone-monitoring satellite, set to launch in 2028 from French Guiana.
Anthia Gillick warns self-improvement groups can mask coercion
AGP
Former OneTaste member Anthia Gillick says cults have adapted to social media and now often present themselves as life coaches, wellness experts and self-help communities.
WMF 2026 brings 3,000 startups and investors to Bologna
AGP
World Startup & VC Fest returns June 24-26 at WMF 2026 in Bologna, drawing more than 3,000 startups, investors, and corporates from 80+ countries.
ABL Diagnostics renews U.S. patent for hepatitis B genotyping technology
AGP
ABL Diagnostics said it has renewed a key U.S. patent covering hepatitis B virus genotyping and antiviral resistance analysis, extending protection for technology used by reference laboratories worldwide.
Sign up for:
Health Network Luxembourg
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.